홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Pioglitazone Hydrochloride

HCID 60560
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
112529-15-4
표준 SMILES
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1.Cl
InChIKey
GHUUBYQTCDQWRA-UHFFFAOYSA-N
분자식
C19H21ClN2O3S
평균 분자량
392.9 g/mol
단동위원소 질량
392.09614121

개요

Pioglitazone hydrochloride is an aromatic ether.

이름 및 식별자

우선 이름
Pioglitazone Hydrochloride
IUPAC
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride
영어명
Pioglitazone hydrochloride
분자식
C19H21ClN2O3S
분자량
392.9

이름 및 동의어

pioglitazone hydrochloride112529-15-4Pioglitazone HClPiomedDiabiomGlidipionGlizofarPioglitazone (as hydrochloride)DTXSID3044203JQT35NPK6CSTR-001Pioglitazonehydrochloride
이름 더 보기
ACTOSPioglitazone hydrochlorid[5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloridePiogPiogLAD-4833U-72107ECAS:112529-15-4
NSC-758876DTXCID1024203OSENI COMPONENT PIOGLITAZONE HYDROCHLORIDEPioglitazone.HClRefChem:56526(5RS)-5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione monohydrochloride5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochlorideU-72107A

데이터베이스 식별자

CAS
112529-15-4
PubChem CID
60560
DTXSID
DTXSID3044203
ChEMBL
CHEMBL1715
ChEBI
CHEBI:8229
UNII
JQT35NPK6C

물성

구조 계산 물성

극성 표면적
93.6 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
5
회전 가능 결합 수
7
무거운 원자 수
26
형식 전하
0
복잡도
466

실험 및 물리화학적 성질

Solubility1.8 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 5건

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Collision Cross Section178 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
193 · 193-194°C
저장 조건
2 · 2-8°C
용해도
10 mg/mL · DMSO: ≥10mg/mL
물리적 상태
가루
색상
흰색에서 황백색까지
수용성
물(25°C에서 <1mg/ml), DMF, 메탄올, 에탄올(25°C에서 4mg/ml) 및 DMSO(25°C에서 79mg/ml)에 용해됩니다.
Merck
14 · 14,7452
BCS Class
2 · 2
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO 용액은 -20°C에서 최대 3개월 동안 보관할 수 있습니다.
주요 응용
의약품(소분자)
InChI
InChI=1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (12.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 57 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (12.3%)

독성 정보

Exposure Routes · 1건

Following oral administration, in the fasting state, pioglitazone is first measurable in serum within 30 minutes, with peak concentrations observed within 2 hours. Food slightly delays the time to peak serum concentration to 3 to 4 hours, but does not alter the extent of absorption.

Toxicity Summary · 1건

Pioglitazone acts as an agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors increases the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, pioglitazone both enhances tissue sensitivity to insulin and reduces hepatic gluconeogenesis. Thus, insulin resistance associated with type 2 diabetes mellitus is improved without an increase in insulin secretion by pancreatic β cells.

Carcinogen Classification2A, probably carcinogenic to humans. (L135)
Drug Induced Liver Injury · 6건

화학 및 산업

약리 정보

Metabolism/MetabolitesHepatic
FDA Pharmacological Classification · 2건

PIOGLITAZONE HYDROCHLORIDE

Peroxisome Proliferator Receptor gamma Agonist [EPC]; Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Thiazolidinediones [CS]; Thiazolidinedione [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]

MeSH Pharmacological ClassificationSubstances which lower blood glucose levels.

용도 및 제조

UsesTreatment of Type II diabetes mellitus
응용 분야 · 3건

개요Pioglitazone is a new orally active thiazolidinedione (TZD) launched in the US for the treatment of non-insulin dependent diabetes mellitus (NIDDM). It can be synthesized in 4 steps, the last one transforming an alphabromoester into thiazolidine with thiourea. As with other representatives in this class, it potently activates the nuclear receptor peroxisome proliferator-activated receptor gamma which is believed to be involved in the regulation of insulin resistance and adipogenesis. In several obese and obese diabetic animal models, treatment with Pioglitazone resulted in reductions in plasma glucose and serum lipids. In clinical studies, Pioglitazone at a once daily oral dose of 15-45 mg, as monotherapy or in combination with non-TZDs or insulin, was shown to significantly improve glycemic control in type-2 diabetes and demonstrated a beneficial effect on insulin resistance and other clinically relevant parameters as plasma levels of triglycerides or HDL-cholesterol. Pioglitazone is reported to be safe and well tolerated and is said to have a lower occurrence of hepatic toxicity as well as a low probability for drug interaction.

용도Pioglitazone hydrochloride is a euglycemic agent,used as an antidiabetic.

관련 반응

9건
반응 기록 만들기
HRID 882709 반응식
HRID 882709반응물로
HRID 1486412 반응식
HRID 1486412반응물로
HRID 1486413 반응식
HRID 1486413반응물로
HRID 1486414 반응식
HRID 1486414반응물로
HRID 1522800 반응식
HRID 1522800반응물로
HRID 2195571 반응식
HRID 2195571반응물로
HRID 2195572 반응식
HRID 2195572반응물로
HRID 2273588 반응식
HRID 2273588반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
EC Number
629-731-9
InChIKey
GHUUBYQTCDQWRA-UHFFFAOYSA-N
SMILES
S1C(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C(=O)NC1=O.[H]Cl

화학적 성질

Colourless Prisms

Drug Induced Liver Injury Rank (DILIrank 2.0)

Pioglitazone hydrochloride

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataHypogycemia; LD<sub>50</sub>=mg/kg (orally in rat)

안전 데이터

wgk
3
HS 번호
29341000
risk_code
36/38-36
hazard_code
Xi
safety_code
22-24/25-26
위험 등급
IRRITANT
Hazard Classifications
Acute Tox. 4 OralCarc. 2
스토리지 클래스
11 - Combustible Solids

일반 설명Pioglitazone hydrochloride is an oral antidiabetic agent used in the treatment of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes.

상·하류 제품 정보

상류 원료

아크릴산메틸브롬화수소메틸산 나트륨Copper(II) oxide5-Ethyl-2-pyridineethanolPalladium hydroxidep-플루오로미트로벤젠아세트산 나트륨수소화나트륨

하류 제품

Pioglitazone